Asparaginase Other names: Colaspase Crisantaspase

Chemical formula: C₁₃₇₇H₂₂₀₈N₃₈₂O₄₄₂S₁₇  PubChem compound: 5460875

Active ingredient description

Asparaginase hydrolyses asparagine to aspartic acid and ammonia. In contrast to normal cells, lymphoblastic tumour cells have a very limited capacity for synthesising asparagine because of a significantly reduced expression of asparagine synthetase. Therefore, they require asparagine which diffuses from the extracellular environment. As a result of asparaginase-induced asparagine depletion in serum, protein synthesis in lymphoblastic tumour cells is disturbed while sparing most normal cells.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
L01XX02 Asparaginase L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents
Discover more medicines within L01XX02

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
SPECTRILA Powder for concentrate for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC

External identifiers

CAS Substance: 9015-68-3
DrugBank Drug: DB00023
KEGG Drug: D02997
PubChem Compound: 5460875
RxNorm Ingredient: 1156
SNOMED-CT Concept: 18780003
Asparaginase (substance)
SNOMED-CT Concept: 371014004
Asparaginase (substance)
UNII Identifier: G4FQ3CKY5R
ASPARAGINASE

Medicines

Asparaginase is an active ingredient of these brands:

United States (US)

  • ERWINAZE as ASPARAGINASE ERWINIA CHRYSANTHEMI
  • RYLAZE as ASPARAGINASE ERWINIA CHRYSANTHEMI

Austria (AT)

Brazil (BR)

Canada (CA)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Italy (IT)

Japan (JP)

Lithuania (LT)

Malta (MT)

Mexico (MX)

Netherlands (NL)

Poland (PL)

Romania (RO)

Singapore (SG)

South Africa (ZA)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.